ncRNA name
hsa-miR-31
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
Src
Cancer name
Gallbladder Cancer
Cancer site
Gallbladder
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Up
Impact of overexpression of ncRNA on chemotherapy resistance
Down
ncRNA differential expression in
cancer
patients vs. healthy people
Down
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Our results demonstrated that miR-31reduced significantly in GBC cells rendering resistance to cisplatin, and upregulated expression of miR-31 augmented chemosensitivity, presenting a therapeutic potential to overcome drug.
Tissue resource
gallbladder cancer tissues and casematched noncancerous tissues
human gallbladder cancer cell lines NOZ
human gallbladder cancer cell lines GBC-SD
Experiment
qRT-PCR,Western blot,Luciferase reporter assay
Institute
Xinhua Hospital, School of Medicine, Shanghai JiaoTong University
the Cell Bank of Type Culture Collection of the Chinese Academy of Sciences
Country
China
Continent
Asia